Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Yuzo Furuya"'
Publikováno v:
International Journal of Urology. 16:161-167
In the last decade, abundant evidence has suggested that the insulin-like growth factor (IGF) family comprises a multi-component network of molecules involved in the regulation of both physiological and pathological growth processes in the prostate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::079720975f93e2b9731ee0d315ff48ae
https://doi.org/10.1111/j.1442-2042.2008.02224.x
https://doi.org/10.1111/j.1442-2042.2008.02224.x
Autor:
Tatsuo Igarashi, Kazuhiro Araki, Yuzo Furuya, Hiroyoshi Suzuki, Tomohiko Ichikawa, Kenichi Mizoguchi, Toyofusa Tobe, Haruo Ito, Hiroomi Nakatsu
Publikováno v:
Urology. 68:1178-1182
Objectives To identify the prognostic factors in patients with recurrent renal cell carcinoma after nephrectomy, various factors were assessed, with special attention to serum immunosuppressive acidic protein (IAP) and its doubling time. Methods Age,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3c623efff253d599271e6331602ea8
https://doi.org/10.1016/j.urology.2006.08.1071
https://doi.org/10.1016/j.urology.2006.08.1071
Autor:
Yusuke Awa, Hiroomi Nakatsu, Tatsuya Okano, Yuzo Furuya, Hiroyoshi Suzuki, Masashi Yano, Ken-ichi Egoshi, Takemasa Ohki, Tomohiko Ichikawa, Kazuo Mikami, Satoru Hamano, Sho Ota
Publikováno v:
International Journal of Urology. 13:1202-1206
Aim: To examine the efficiency of α1-blocker treatment on disease-specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic hyperplasia (BPH), the improvement of QOL scores with International prostate symptom score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9527ca0057f49bc579f81f1d4b72e8ad
https://doi.org/10.1111/j.1442-2042.2006.01594.x
https://doi.org/10.1111/j.1442-2042.2006.01594.x
Publikováno v:
International Urology and Nephrology. 35:189-192
The clinical and pathological features of metastatic prostate cancer with normal level of serum prostate-specific antigen (PSA) were investigated. Four patients with metastatic prostate cancer had serum PSA within the normal range at the diagnosis. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50456ab9cfa5e055656a9dfa17157ea9
https://doi.org/10.1023/b:urol.0000020306.08275.49
https://doi.org/10.1023/b:urol.0000020306.08275.49
Publikováno v:
Endocrine Journal. 50:629-633
To evaluate the clinical usefulness of serum soluble Fas (sFas) and sFas ligand as a prognostic factor and for monitoring the regression and progression of metastatic prostate cancer treated with endocrine therapy, sFas and sFas ligand were measured
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57933288e96f960ec09828a358256430
https://doi.org/10.1507/endocrj.50.629
https://doi.org/10.1507/endocrj.50.629
Publikováno v:
Urology. 60:527-530
Objectives. To clarify whether serum levels of pro-gastrin-releasing peptide (ProGRP) (31-98) could be a useful marker in patients with prostatic carcinoma. GRP is produced and secreted by prostatic neuroendocrine cells. Methods. Serum levels of ProG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359b51105c3c8889ac5bc1edbdfc315a
https://doi.org/10.1016/s0090-4295(02)01774-0
https://doi.org/10.1016/s0090-4295(02)01774-0
Autor:
Hiroyoshi Suzuki, Masatoshi Watanabe, Takashi Imamoto, Takeshi Ueda, Akira Komiya, Tomohiko Ichikawa, Yuzo Furuya, Haruo Ito, Taizo Shiraishi, Koichiro Akakura
Publikováno v:
The Prostate. 51:219-224
BACKGROUND Several investigators have examined the clinical significance of the length of the CAG repeat at the N-terminal region of the androgen receptor in the pathogenesis of prostate cancer. Because the clinical significance of CAG repeat length
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3619b45cbbcd11df00531a3cad7222a3
https://doi.org/10.1002/pros.10080
https://doi.org/10.1002/pros.10080
Publikováno v:
Endocrine Journal. 49:85-90
Patients with prostate cancer generally respond to androgen withdrawal therapy, but progression to androgen-independence is frequently observed later. To examine whether pretreatment serum androgen status could predict disease progression in metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1449c7f52bc8c3a65140aeeaa79a8e48
https://doi.org/10.1507/endocrj.49.85
https://doi.org/10.1507/endocrj.49.85
Publikováno v:
International Urology and Nephrology. 33:73-76
In order to examine the characteristics of patients with nonpalpable prostate cancer (T1c cancer) in Japan, patients treated with radical prostatectomy were compared with those with palpable (T2) cancer. Prostate-specific antigen (PSA) level in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ded8feb5195232594d1d63afbbc38a1c
https://doi.org/10.1023/a:1014461105701
https://doi.org/10.1023/a:1014461105701
Autor:
Yuzo Furuya, Hiroshi Ito, Koichiro Akakura, Toyofusa Tobe, Tomohiko Ichikawa, Tatsuo Igarashi
Publikováno v:
International Urology and Nephrology. 32:659-663
Patients with metastatic prostate cancer respond to androgen withdrawal therapy, but progression to androgen independence is frequently observed. To clarify the predictor of response to endocrine therapy, the role of PSA changes and the prognosis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b00d6c61a45b226069cee941ea77560f
https://doi.org/10.1023/a:1014410026495
https://doi.org/10.1023/a:1014410026495